Korro Bio

Korro Bio is creating transformative therapeutics for patients by selectively editing messenger RNA to recode specific codons to deliver a beneficial change in protein sequence, structure and function. Korro Bio’s foundational technology is poised to provide an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms. Korro Bio is prioritizing therapeutic indications across tissues where safe and targeted editing of messenger RNA could provide unique benefits over other modalities in development.

Headquarters Cambridge, MA
Website www.korrobio.com​
Pipeline Preclinical
Twitter @korrobio